Accelerated erythrocyte senescence causes dose-limiting anemia of antimalarial enolase inhibitors
By
Andrew J. Jezewski,
Yu-Hsi Lin,
Julie A. Reisz,
Rachel Culp-Hill,
Yasaman Barekatain,
Victoria C. Yan,
Angelo D’Alessandro,
Florian L Muller,
Audrey R Odom John
Posted 10 Oct 2020
bioRxiv DOI: 10.1101/2020.10.09.331728
Glycolysis controls cellular energy, redox balance, and biosynthesis. Antiglycolytic therapies are being investigated for obesity, cancer, aging, autoimmunity, and microbial diseases. Interrupting glycolysis is highly valued as a therapeutic strategy, because glycolytic disruption is generally tolerated in mammals. Unfortunately, anemia is a key dose-limiting side effect of these inhibitors and presents a major caveat to development of antiglycolytic therapies. We developed specific inhibitors of enolase (a critical enzyme in glycolysis) and validated their metabolic and cellular effects on human erythrocytes. Enolase inhibition increases erythrocyte susceptibility to oxidative damage that induces rapid and premature erythrocyte senescence, rather than direct hemolysis. We apply our model of red cell toxicity to address questions regarding erythrocyte glycolytic disruption in the context of malaria pathogenesis. Our study provides a framework for understanding red blood cell homeostasis under normal and disease states and clarifies the importance of erythrocyte reductive capacity. ### Competing Interest Statement The authors have declared no competing interest.
Download data
- Downloaded 106 times
- Download rankings, all-time:
- Site-wide: 115,118
- In pharmacology and toxicology: 956
- Year to date:
- Site-wide: 28,215
- Since beginning of last month:
- Site-wide: 48,073
Altmetric data
Downloads over time
Distribution of downloads per paper, site-wide
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!